The largest database of trusted experimental protocols

4 protocols using si03650325

1

Modulating miR-27a in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic miR-27a mimic (Syn-hsa-miR-27a), miR-27a inhibitor (anti-hsa-miR-27a) or the appropriate scrambled controls (AllStar or mirScript Inhibitor-Negative Control) were purchased from Qiagen (Hilden, Germany). The miR-27a-antisense (MZIP27a-PA-1), the pre-miR-27a expression constructs (PMIRH27a-onlyPA-1) and scrambled control miRNAs (MZIP000-PA-1; PMIRH000PA-1) plasmids (System Biosciences, Mountain View, CA, USA) were transfected in the different CRC cell lines. microRNA functional studies were performed by inhibiting miRNA-mRNA target interactions either with a custom-designed calreticulin-miScript Target Protector or a negative control miScript Target Protector (MTP0075035; Qiagen). Detection of no variations in unrelated proteins validated target protector specificity. A gene-specific package of three preselected siRNAs against calreticulin (Flexi Tube siRNA GS811) or a negative control siRNA (SI03650325) (Qiagen) was used in transient transfections. Functional assays, RNA and protein analyses were performed within 24/72 h from transfections. In each experiment, the extent of miR-27a silencing/overexpression was assessed by qRT-PCR. Plasmids and oligonucleotides were transfected using Lipofectamine 2000 (Thermo Fisher, Waltham, MA, USA) and HiPerFect Transfection Reagent (Qiagen) or RNAi Max (Thermo Fisher), respectively, according to the manufacturers' recommendations.
+ Open protocol
+ Expand
2

Rat CD9+ Cells Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD9-positive cells prepared from Wistar rats were plated at 2.0 × 104 cells/cm2 or 1.0 × 105 cells/cm2 on 8-well glass chamber slides with laminin-coated surfaces. Cells were then cultured for 24 h in 400 μL Medium 199 with 10% FBS (Merck Millipore) at 37 °C in a humidified atmosphere of 5% CO2 and 95% air. For transfection of siRNAs, the culture medium was replaced with 400 μL of Medium 199 with 10% FBS (Thermo Fisher Scientific) supplemented with transfection reagent (INTERFERin at 1:100 v/v; PolyPlus Transfection, Illkirch, France) and siRNAs against Cd9 mRNA (0.2 μM Rn_Cd9_1; Qiagen, Venlo, Netherlands) in wells with cells plated at a density of 1.0 × 105 cells/cm2 or siRNAs against Id2 mRNA (0.2 μM Rn_Id2_1; Qiagen) in wells with cells plated at a density of 2.0 × 104 cells/cm2, followed by further cultivation for 48 and 120 h, respectively. A non-silencing siRNA without homology to any known mammalian gene was used as a negative control (SI03650325;Qiagen). After cultivation, cells were used for proliferation assays and immunocytochemistry.
+ Open protocol
+ Expand
3

Downregulation of RECQ1 and FEN-1 in HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HeLa (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (Hyclone Laboratories), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen). Cells were grown in a humidified 5% CO2 incubator at 37°C. Stable downregulation of RECQ1 was achieved by transducing HeLa cells with lentiviral shRNA as described [13 (link)]. Control HeLa cells were similarly transduced with a shRNA targeting the gene encoding Luciferase. FEN-1 was transiently knocked down in HeLa cells using a synthetic siRNA against FEN-1 (Qiagen, SI02663451), or a non-silencing control siRNA (Qiagen, SI03650325). Cells were reverse transfected with siRNA (20 nM) using Lipofectamine RNAiMAX (Invitrogen) as instructed by the manufacturer.
+ Open protocol
+ Expand
4

Silencing CD9 and CD81 in Mammary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD9-positive cells isolated from rat mammary glands were plated at a density of 1.0 × 105 cells/cm2 on 8-well glass chamber slides coated
with laminin. The cells were then cultured at 37°C for 24 h in 400 μl of Medium 199 containing 10% FBS (Merck Millipore) in a humidified atmosphere of 5%
CO2 and 95% air. For small INTERFERing RNA (siRNA) transfection, the culture medium was replaced with 400 μl of Medium 199 containing 10% FBS
(Thermo Fisher Scientific) supplemented with the transfection reagent INTERFERin (1:100 v/v; PolyPlus Transfection, Illkirch, France) and siRNAs against
Cd9 or/and Cd81 (0.2 μM Mm_Cd9_1 and Mm_Cd81_2; Qiagen), and the cells were incubated for
48 h. An siRNA without homology to any known mammalian gene was used as the negative control (SI03650325; Qiagen). The cultivated cells were used for
proliferation assays and immunocytochemistry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!